{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:54:08Z","timestamp":1791179648595,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-014-0744-4","type":"journal-article","created":{"date-parts":[[2015,1,7]],"date-time":"2015-01-07T17:09:01Z","timestamp":1420650541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC\u00ae) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial"],"prefix":"10.1186","volume":"15","author":[{"given":"Ki Wook","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoan Jong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Han","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Wook","family":"Eun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yae-Jean","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Hyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwang Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Ho","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,8]]},"reference":[{"key":"744_CR1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1056\/NEJMra030476","volume":"351","author":"T Solomon","year":"2004","unstructured":"Solomon T. Flavivirus encephalitis. N Engl J Med. 2004;351:370\u20138.","journal-title":"N Engl J Med"},{"key":"744_CR2","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJMp058263","volume":"355","author":"T Solomon","year":"2006","unstructured":"Solomon T. Control of Japanese encephalitis\u2013within our grasp? N Engl J Med. 2006;355:869\u201371.","journal-title":"N Engl J Med"},{"key":"744_CR3","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1016\/j.vaccine.2005.10.054","volume":"24","author":"SE Yang","year":"2006","unstructured":"Yang SE, Pan MJ, Tseng HF, Liau MY. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine\u2013results from 30\u00a0years experience in Taiwan. Vaccine. 2006;24:2669\u201373.","journal-title":"Vaccine"},{"key":"744_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1586\/erv.11.7","volume":"10","author":"SB Halstead","year":"2011","unstructured":"Halstead SB, Thomas SJ. New Japanese encephalitis vaccines: alternatives to production in mouse brain. Expert Rev Vaccines. 2011;10:355\u201364.","journal-title":"Expert Rev Vaccines"},{"key":"744_CR5","doi-asserted-by":"publisher","first-page":"8669","DOI":"10.1016\/j.vaccine.2011.08.117","volume":"29","author":"E Schuller","year":"2011","unstructured":"Schuller E, Klingler A, Dubischar-Kastner K, Dewasthaly S, Muller Z. Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO((R)). Vaccine. 2011;29:8669\u201376.","journal-title":"Vaccine"},{"key":"744_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.7774\/cevr.2012.1.1.3","volume":"1","author":"SH Cha","year":"2012","unstructured":"Cha SH. The history of vaccination and current vaccination policies in Korea. Clin Exp Vaccine Res. 2012;1:3\u20138.","journal-title":"Clin Exp Vaccine Res"},{"key":"744_CR7","unstructured":"KCDC: The Global status of vaccine development regarding Japanese encephalitis in Korea and other countries; 2011 December 9."},{"key":"744_CR8","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","volume":"370","author":"E Tauber","year":"2007","unstructured":"Tauber E, Kollaritsch H, Korinek M, Rendi-Wagner P, Jilma B, Firbas C, et al. Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial. Lancet. 2007;370:1847\u201353.","journal-title":"Lancet"},{"key":"744_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1086\/590116","volume":"198","author":"E Tauber","year":"2008","unstructured":"Tauber E, Kollaritsch H, von Sonnenburg F, Lademann M, Jilma B, Firbas C, et al. Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine. J Infect Dis. 2008;198:493\u2013299.","journal-title":"J Infect Dis"},{"key":"744_CR10","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.vaccine.2012.01.054","volume":"30","author":"A Kikukawa","year":"2012","unstructured":"Kikukawa A, Gomi Y, Akechi M, Onishi T, Manabe S, Namazue J, et al. Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated). Vaccine. 2012;30:2329\u201335.","journal-title":"Vaccine"},{"key":"744_CR11","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.vaccine.2009.10.024","volume":"28","author":"A Kaltenbock","year":"2010","unstructured":"Kaltenbock A, Dubischar-Kastner K, Schuller E, Datla M, Klade CS, Kishore TS. Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3\u00a0years of age. Vaccine. 2010;28:834\u20139.","journal-title":"Vaccine"},{"key":"744_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1128\/CVI.00377-13","volume":"21","author":"C Miyazaki","year":"2014","unstructured":"Miyazaki C, Okada K, Ozaki T, Hirose M, Iribe K, Yokote H, et al. Phase III clinical trials comparing the immunogenicity and safety of Vero cell-derived Japanese encephalitis vaccine ENCEVAC(R) with those of mouse brain-derived vaccine using the Beijing-1 strain. Clin Vaccine Immunol. 2014;21:188\u201395.","journal-title":"Clin Vaccine Immunol"},{"key":"744_CR13","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0264-410X(02)00772-7","volume":"21","author":"M Abe","year":"2003","unstructured":"Abe M, Kuzuhara S, Kino Y. Establishment of an analyzing method for a Japanese encephalitis virus neutralization test in Vero cells. Vaccine. 2003;21:1989\u201394.","journal-title":"Vaccine"},{"key":"744_CR14","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","volume":"23","author":"J Hombach","year":"2005","unstructured":"Hombach J, Solomon T, Kurane I, Jacobson J, Wood D. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004. Vaccine. 2005;23:5205\u201311.","journal-title":"Vaccine"},{"key":"744_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/cid\/cis542","volume":"55","author":"EO Erra","year":"2012","unstructured":"Erra EO, Askling HH, Rombo L, Riutta J, Vene S, Yoksan S, et al. A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines. Clin Infect Dis. 2012;55:825\u201334.","journal-title":"Clin Infect Dis"},{"key":"744_CR16","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1056\/NEJM198809083191004","volume":"319","author":"CH Hoke","year":"1988","unstructured":"Hoke CH, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis BL, et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med. 1988;319:608\u201314.","journal-title":"N Engl J Med"},{"key":"744_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1517\/14712598.8.1.95","volume":"8","author":"DW Beasley","year":"2008","unstructured":"Beasley DW, Lewthwaite P, Solomon T. Current use and development of vaccines for Japanese encephalitis. Expert Opin Biol Ther. 2008;8:95\u2013106.","journal-title":"Expert Opin Biol Ther"},{"key":"744_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0140-6736(05)66156-9","volume":"348","author":"AM Plesner","year":"1996","unstructured":"Plesner AM, Arlien-Soborg P, Herning M. Neurological complications and Japanese encephalitis vaccination. Lancet. 1996;348:202\u20133.","journal-title":"Lancet"},{"key":"744_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.idc.2004.11.004","volume":"19","author":"AA Marfin","year":"2005","unstructured":"Marfin AA, Eidex RS, Kozarsky PE, Cetron MS. Yellow fever and Japanese encephalitis vaccines: indications and complications. Infect Dis Clin North Am. 2005;19:151\u201368.","journal-title":"Infect Dis Clin North Am"},{"key":"744_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1006\/biol.2002.0345","volume":"30","author":"K Sugawara","year":"2002","unstructured":"Sugawara K, Nishiyama K, Ishikawa Y, Abe M, Sonoda K, Komatsu K, et al. Development of Vero cell-derived inactivated Japanese encephalitis vaccine. Biologicals. 2002;30:303\u201314.","journal-title":"Biologicals"},{"key":"744_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1586\/14760584.2013.835638","volume":"12","author":"T Jelinek","year":"2013","unstructured":"Jelinek T. IXIARO updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis. Expert Rev Vaccines. 2013;12:859\u201369.","journal-title":"Expert Rev Vaccines"},{"key":"744_CR22","unstructured":"CDC: Use of Japanese encephalitis vaccine in children: recommendations of the advisory committee on immunization practices, 2013, 2013 Nov 15."},{"key":"744_CR23","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1016\/j.vaccine.2012.07.034","volume":"30","author":"K Okada","year":"2012","unstructured":"Okada K, Iwasa T, Namazue J, Akechi M, Ueda S. Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK((R))V) in children. Vaccine. 2012;30:5967\u201372.","journal-title":"Vaccine"},{"key":"744_CR24","first-page":"55","volume":"70","author":"TC Hsu","year":"1971","unstructured":"Hsu TC, Chow LP, Wei HY, Chen CL, Hsu ST. A controlled field trial for an evaluation of effectiveness of mouse-brain Japanese encephalitis vaccine. Taiwan Yi Xue Hui Za Zhi. 1971;70:55\u201362.","journal-title":"Taiwan Yi Xue Hui Za Zhi"},{"issue":"Suppl 2","key":"744_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0264-410X(00)00038-4","volume":"18","author":"L Markoff","year":"2000","unstructured":"Markoff L. Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines. Vaccine. 2000;18 Suppl 2:26\u201332.","journal-title":"Vaccine"},{"key":"744_CR26","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1016\/j.vaccine.2010.05.069","volume":"28","author":"K Dubischar-Kastner","year":"2010","unstructured":"Dubischar-Kastner K, Eder S, Buerger V, Gartner-Woelfl G, Kaltenboeck A, Schuller E, et al. Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51. Vaccine. 2010;28:5197\u2013202.","journal-title":"Vaccine"},{"key":"744_CR27","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1016\/j.vaccine.2011.01.058","volume":"29","author":"S Eder","year":"2011","unstructured":"Eder S, Dubischar-Kastner K, Firbas C, Jelinek T, Jilma B, Kaltenboeck A, et al. Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO(R), IC51. Vaccine. 2011;29:2607\u201312.","journal-title":"Vaccine"},{"key":"744_CR28","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1016\/j.vaccine.2012.02.063","volume":"26","author":"T Woolpert","year":"2012","unstructured":"Woolpert T, Staples JE, Faix DJ, Nett RJ, Kosoy OI, Biggerstaff BJ, et al. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine. Vaccine. 2012;26:3090\u20136.","journal-title":"Vaccine"},{"key":"744_CR29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/1743-422X-8-449","volume":"8","author":"R Takhampunya","year":"2011","unstructured":"Takhampunya R, Kim HC, Tippayachai B, Kengluecha A, Klein TA, Lee WJ, et al. Emergence of Japanese encephalitis virus genotype V in the Republic of Korea. Virol J. 2011;8:449.","journal-title":"Virol J"},{"issue":"Suppl 2","key":"744_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0264-410X(00)00041-4","volume":"18","author":"I Kurane","year":"2000","unstructured":"Kurane I, Takasaki T. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains. Vaccine. 2000;18 Suppl 2:33\u20135.","journal-title":"Vaccine"},{"key":"744_CR31","first-page":"689","volume":"26","author":"S Nimmannitya","year":"1995","unstructured":"Nimmannitya S, Hutamai S, Kalayanarooj S, Rojanasuphot S. A field study on Nakayama and Beijing strains of Japanese encephalitis vaccines. Southeast Asian J Trop Med Public Health. 1995;26:689\u201393.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"744_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/jmv.1890440204","volume":"44","author":"CC Ku","year":"1994","unstructured":"Ku CC, King CC, Lin CY, Hsu HC, Chen LY, Yueh YY, et al. Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children. J Med Virol. 1994;44:122\u201331.","journal-title":"J Med Virol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-014-0744-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0744-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:03:25Z","timestamp":1630566205000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-014-0744-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,8]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["744"],"URL":"https:\/\/doi.org\/10.1186\/s12879-014-0744-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,8]]},"assertion":[{"value":"27 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}